Subscribe To
2 best biotech stocks to buy right now
These two pharma stocks boast 3%-plus dividend yields, double the S&P 500 index's 1.5% dividend yield....
June 11, 2022, 10:53 am
Praxis: mdd trial failure may not mean an end to entire pipeline
A phase 2/3 trial failure in the MDD indication of PRAX-114 allows this biotech to shift focus over to ...
June 10, 2022, 2:45 pm
4 biotech stocks with bright prospects to buy amid recovery
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfo...
June 10, 2022, 1:33 pm
Ergomed appoints former gsk and sanofi executive to board
Ergomed PLC (AIM:ERGO, ETR:2EM) said Anne Whitaker will join its board as an independent non-executive director after the pharmaceutical industry ser...
June 10, 2022, 4:02 am
Top penny stocks to buy? 4 biotech stocks to watch now
biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?...
June 9, 2022, 7:20 pm
Ocugen, inc. to present at bio international convention 2022
MALVERN, Pa., June 09, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercia...
June 9, 2022, 6:17 pm
Why dbv technologies stock popped again today
The French biotech kept its upward momentum going with news of nearly $200 million in fresh funding....
June 9, 2022, 5:41 pm
Seres therapeutics: as biotech fades the case for seres investment strengthens
Seres Therapeutics reports new data concerning safety and effectiveness of SER-109 for treating recurrent C.difficile infection. This completes Seres ...
June 9, 2022, 12:08 pm
Xbi or ibb: how to play the oversold biotech most efficiently
Biotechnology sector stocks seem to be in the oversold zone, as indicated by their momentum and valuations. I compared XBI (small-cap ...
June 9, 2022, 8:51 am
An innovative etf opportunity that taps into our increased understanding of the human genome
With a targeted disruptive innovation biotechnology-related exchange traded fund strategy, investors can focus on companies driving change in targeted...
June 8, 2022, 7:05 pm
Novavax covid-19 vaccine recommended for us approval by fda advisory panel
Novavax, Inc. (NASDAQ:NVAX) said its Covid-19 vaccine has been recommended for approval by the US Food and Drug Administration (FDA) Vaccines and Rela...
June 8, 2022, 4:46 am
Why veru stock surged today
The biotech's experimental oral COVID-19 treatment could be a game changer....
June 7, 2022, 7:06 pm
Change the dna of your portfolio: growth opportunities through genomics
Thanks to DNA sequencing and the genomic revolution, we could be on the cusp of a brand-new era of healthcare solutions that could extend and enhance ...
June 7, 2022, 7:02 pm
Basic could be beautiful when biotech bounces back
Biotechnology stocks and exchange traded funds are into a second year of disappointing investors, but that condition won't be permanent. With that in ...
June 7, 2022, 11:01 am
Cardiff oncology: upcoming readouts and several green lights
Cardiff Oncology started taking a beating from the early days of the biotech bear market, in September ...
June 7, 2022, 10:51 am
Why is aikido pharma (aiki) stock up 1,400%?
AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company. The post Why Is AIkido Pha...
June 7, 2022, 10:39 am
Abbvie is the preeminent large-cap name in biotech, says piper sandler's raymond
Christopher Raymond, Piper Sander senior biotech analyst, joins 'Power Lunch' to discuss what it means ...
June 6, 2022, 3:40 pm
Havn life to present at upcoming ld micro invitational xii
CEO, Tim Moore will share recent partnership and distribution news and a roadmap for the Company's plans for the next quarterVancouver, British Columb...
June 6, 2022, 11:38 am
Abcellera biologics: fully funded, with new opportunities and massive insider buying
AbCellera stock has continued to struggle of late given the absolutely terrible sentiment in the biotech ...
June 6, 2022, 7:24 am
biotech etfs strengthen as bristol myers squibb buys turning point
Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers Squibb Co. (NYSE: BMY) said it will acquire dru...
June 3, 2022, 6:51 pm